{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:33:12Z","timestamp":1789522392364,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtct.2026.07.031","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:43:10Z","timestamp":1785368590000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nosocomial Respiratory Virus Infections in Hematologic Malignancies: Risk Factors for Progression to Lower Respiratory Tract Infection"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8041-1638","authenticated-orcid":false,"given":"Keon","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Gun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dukhee","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Mi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daehun","family":"Kwag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1168-3666","authenticated-orcid":false,"given":"Raeseok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.07.031_bib0001","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/S1473-3099(25)00365-2","article-title":"Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia","volume":"26","author":"von Lilienfeld-Toal","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jtct.2026.07.031_bib0002","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.bmt.1703139","article-title":"Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation","volume":"28","author":"Ljungman","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.031_bib0003","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/jac\/dkt111","article-title":"Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections","volume":"68","author":"Shah","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jtct.2026.07.031_bib0004","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bbmt.2018.03.004","article-title":"Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing","volume":"24","author":"Sim","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.031_bib0005","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1186\/s12889-023-17406-9","article-title":"Spatiotemporal variations of \"triple-demic\" outbreaks of respiratory infections in the United States in the post-COVID-19 era","volume":"23","author":"Luo","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jtct.2026.07.031_bib0006","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3324\/haematol.2018.215152","article-title":"Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies","volume":"104","author":"Khawaja","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.07.031_bib0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbmt.2018.08.021","article-title":"Risk factors for parainfluenza virus lower respiratory tract disease after hematopoietic cell transplantation","volume":"25","author":"Seo","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.031_bib0008","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/infdis\/jit832","article-title":"Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease","volume":"209","author":"Kim","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jtct.2026.07.031_bib0009","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2013-12-541359","article-title":"Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections","volume":"123","author":"Shah","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.07.031_bib0010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cmi.2023.04.021","article-title":"Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"29","author":"Manothummetha","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jtct.2026.07.031_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148258","article-title":"Long-term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders","volume":"11","author":"Lehners","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2026.07.031_bib0012","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/cid\/cit725","article-title":"The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts","volume":"58","author":"Memoli","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2026.07.031_bib0013","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2026.07.031_bib0014","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity score weighting","volume":"113","author":"Li","year":"2018","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jtct.2026.07.031_bib0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3947\/ic.2019.51.2.98","article-title":"The National Influenza Surveillance System of Korea","volume":"51","author":"Choi","year":"2019","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jtct.2026.07.031_bib0016","first-page":"641","article-title":"The Republic of Korea 2023-2024 Influenza and Respiratory Viruses Laboratory Surveillance Report [Korean]","volume":"18","author":"Woo","year":"2025","journal-title":"Jugan Geongang Gwa Jilbyeong"},{"key":"10.1016\/j.jtct.2026.07.031_bib0017","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbmt.2005.07.007","article-title":"Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies","volume":"11","author":"Martino","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.031_bib0018","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41409-022-01575-z","article-title":"Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients","volume":"57","author":"Ogimi","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.031_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12994","article-title":"Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies","volume":"20","author":"Vakil","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2026.07.031_bib0020","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00277-020-03996-6","article-title":"Immunodeficiency risk score for prediction of mortality by parainfluenza virus infection in patients with hematologic malignancy","volume":"99","author":"Lee","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2026.07.031_bib0021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/509930","article-title":"Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients","volume":"44","author":"Boeckh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2026.07.031_bib0022","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1093\/cid\/ciab113","article-title":"DAS181 treatment of severe lower respiratory tract parainfluenza virus infection in immunocompromised patients: a phase 2 randomized, placebo-controlled study","volume":"73","author":"Chemaly","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2026.07.031_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2024.0011","article-title":"Epidemiology and disease burden of respiratory syncytial virus infection in adults","volume":"56","author":"Kim","year":"2024","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jtct.2026.07.031_bib0024","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3904\/kjim.2023.508","article-title":"Impact of the coronavirus disease 2019 pandemic on the incidence of other infectious diseases in the hematology hospital in Korea","volume":"39","author":"Oh","year":"2024","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jtct.2026.07.031_bib0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/irv.12379","article-title":"Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review","volume":"10","author":"French","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jtct.2026.07.031_bib0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13756-018-0316-2","article-title":"Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease","volume":"7","author":"Baier","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jtct.2026.07.031_bib0027","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/bmt.2010.67","article-title":"Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program","volume":"46","author":"Lavergne","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.031_bib0028","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2024.39.e171","article-title":"Epidemiology of respiratory viruses in Korean children before and after the COVID-19 pandemic: a prospective study from National Surveillance System","volume":"39","author":"Cho","year":"2024","journal-title":"J Korean Med Sci"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:33:50Z","timestamp":1787398430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726005932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"alternative-id":["S2666636726005932"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.031","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nosocomial Respiratory Virus Infections in Hematologic Malignancies: Risk Factors for Progression to Lower Respiratory Tract Infection","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}